Inhibitor Therapeutics, Inc. Public Float
Inhibitor Therapeutics, Inc. (INTI) had Public Float of $3.30 million as of 2025-06-30, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-26
- 2025-06-30: Entity Public Float $3.30M.
- 2024-06-30: Entity Public Float $6.60M.
- 2023-06-30: Entity Public Float $3.20M.
- 2022-06-30: Entity Public Float $7.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $3.30M 10-K · filed 2026-03-26 |
| 2024-06-30 | $6.60M 10-K · filed 2025-03-28 |
| 2023-06-30 | $3.20M 10-K · filed 2024-03-29 |
| 2022-06-30 | $7.80M 10-K · filed 2023-03-31 |
| 2021-06-30 | $18.77M 10-K · filed 2022-03-30 |
| 2020-06-30 | $7.40M 10-K · filed 2021-03-26 |
| 2019-06-30 | $6.23M 10-K · filed 2020-03-30 |
| 2018-06-30 | $24.88M 10-K · filed 2019-03-07 |
| 2017-06-30 | $47.02M 10-K · filed 2018-02-16 |
| 2016-06-30 | $11.62M 10-K · filed 2017-02-17 |
| 2015-06-30 | $2.02M 10-K · filed 2016-02-01 |
| 2014-06-30 | $1.78M 10-K · filed 2015-02-13 |
| 2013-06-28 | $152.74K 10-K · filed 2014-04-15 |